CIBACRON BLUE 3G-A

CAS No. 84166-13-2

CIBACRON BLUE 3G-A( —— )

Catalog No. M20191 CAS No. 84166-13-2

Anthraquinone derivative dye. Potent nucleotide-mimetic ligand

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 38 In Stock
25MG 52 In Stock
50MG 67 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CIBACRON BLUE 3G-A
  • Note
    Research use only, not for human use.
  • Brief Description
    Anthraquinone derivative dye. Potent nucleotide-mimetic ligand
  • Description
    Anthraquinone derivative dye. Potent nucleotide-mimetic ligand.
  • In Vitro
    Cibacron Blue 3G-A is a structural analogy between the dye and NADH, it interacts with (di)nucleotide-dependent enzymes and can be a standard tool for studying their active sites.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    84166-13-2
  • Formula Weight
    774.2
  • Molecular Formula
    C29H20ClN7O11S3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 62.5 mg/mL (80.73 mM)
  • SMILES
    Nc1c(cc(Nc2ccc(Nc3nc(Cl)nc(Nc4ccccc4S(O)(=O)=O)n3)c(c2)S(O)(=O)=O)c2C(=O)c3ccccc3C(=O)c12)S(O)(=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Vopratelimab

    Vopratelimab (JTX-2011) is a selective humanized immunoglobulin G1-kappa monoclonal antibody and a potent ICOS agonist with high affinity for inducible T cell co-stimulating factors (ICOS), showing affinities of 0.93 nM for hICOS, 3.7 nM for rat ICOS, and 0.64 nM for mICOS.

  • NSC243928 mesylate

    NSC243928 mesylate binds to human lymphocyte antigen 6 (LY6), a cell growth inhibitor with anticancer activity, and induces cell death in triple-negative breast cancer cells in a LY6K-dependent manner.

  • Adelmidrol

    Adelmidrol is an anti-inflammatory ethanolamide derivative of azelaic acid.